Health Care Professionals Log In

Using the ClickCase™

The unique ClickCase™9 contains 28 "active" (hormone-containing) yellow pills and features a discreet, convenient design that allows patients to dispense each pill quickly and easily.

How to use the ClickCase™:

Have a patient decide what time of day she wants to take her pill. It is important for her to take her pill at about the same time every day.1 This will maximize the pill’s ability to prevent pregnancy,1 plus help her minimize breakthrough bleeding and spotting and stick with a routine.

To use the ClickCase™, follow these 3 steps:1

Step 1 – Look at your ClickCase™ dispenser. Find the pill window and day indicator. Place the case lengthwise in the palm of your hand, so that the pill window and day indicator are visible.

Step 2 – Make note of the day that lines up with the window. If the desired start day is not aligned with the window, firmly squeeze the ends of the case together until it clicks. Then fully RELEASE. Keep clicking and releasing until you reach the desired start day.

Step 3 – To take your pill, firmly squeeze the ends of the case together until it clicks; do NOT release. Turn the case over and allow the pill to drop out into your other hand. Before releasing, turn the case back over, then fully RELEASE, and the next day’s pill automatically advances.

Patients on LYBREL® should be sure to have ready at all times1:

  • Another kind of nonhormonal birth control (such as condoms and/or spermicide) to use as a backup in case she misses pills.
  • An extra, full pill pack. A patient should always remember to refill her prescription so she has an extra, full pill pack on hand. This way she can continue taking her pill each day, without interruption.

You can also download and print these steps and give copies to patient candidates for LYBREL in your office.

Download Using the ClickCase™. Requires Adobe® Reader®

Get Adobe® Reader®

Next: If a Patient Misses a Pill »

Important Safety Information

  • Oral contraceptives (OCs) do not protect against HIV infection or other sexually transmitted diseases.
  • When prescribing LYBREL, the convenience of having no scheduled menstrual bleeding should be weighed against the inconvenience of unscheduled breakthrough bleeding and spotting.
  • OCs are contraindicated in women who have blood clots; breast, uterine, or liver cancers; a history of heart attack, stroke, or breast cancer; as well as those who are or may be pregnant.
The risks of serious cardiovascular side effects are substantially increased in women who smoke and use OCs, especially in women over age 35. Women who use oral contraceptives should be strongly advised not to smoke.
  • Serious risks associated with OCs include blood clots, heart attack, and stroke.
  • LYBREL provides women with more hormonal exposure on a yearly basis (13 additional weeks of hormone intake per year) than conventional cyclic oral contraceptives containing the same strength of synthetic estrogens and similar strength of progestins.
  • Scheduled withdrawal bleeding does not occur with the use of LYBREL, therefore, the absence of withdrawal bleeding cannot be used as a sign of an unexpected pregnancy and as such, unexpected pregnancy may be difficult to recognize. Although pregnancy is unlikely if LYBREL is taken as directed, if for any reason, pregnancy is suspected in a woman using LYBREL, a pregnancy test should be performed.
  • The most commonly reported treatment emergent adverse events reported with LYBREL in a clinical trial were headache, dysmenorrhea, upper respiratory infection, vaginal bleeding (defined as metrorrhagia and vaginal hemorrhage), and nausea.

Registration | Unsubscribe | E-mail This Page | Patient Awareness | References

236749-01

LYBREL and LYBREL with icon are registered trademarks of Wyeth.